vs
Harmony Biosciences Holdings, Inc.（HRMY）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Harmony Biosciences Holdings, Inc.的季度营收约是Ribbon Communications Inc.的1.5倍（$243.8M vs $162.6M），Ribbon Communications Inc.净利率更高（54.8% vs 9.2%，领先45.5%），Harmony Biosciences Holdings, Inc.同比增速更快（21.1% vs -10.3%），过去两年Harmony Biosciences Holdings, Inc.的营收复合增速更高（25.6% vs -8.1%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
HRMY vs RBBN — 直观对比
营收规模更大
HRMY
是对方的1.5倍
$162.6M
营收增速更快
HRMY
高出31.4%
-10.3%
净利率更高
RBBN
高出45.5%
9.2%
两年增速更快
HRMY
近两年复合增速
-8.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $162.6M |
| 净利润 | $22.5M | $89.1M |
| 毛利率 | 71.9% | 42.9% |
| 营业利润率 | 15.8% | 37.6% |
| 净利率 | 9.2% | 54.8% |
| 营收同比 | 21.1% | -10.3% |
| 净利润同比 | -54.6% | — |
| 每股收益（稀释后） | $0.38 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRMYRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $243.8M | $227.3M | ||
| Q3 25 | $239.5M | $215.4M | ||
| Q2 25 | $200.5M | $220.6M | ||
| Q1 25 | $184.7M | $181.3M | ||
| Q4 24 | $201.3M | $251.4M | ||
| Q3 24 | $186.0M | $210.2M | ||
| Q2 24 | $172.8M | $192.6M |
净利润HRMYRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $22.5M | — | ||
| Q3 25 | $50.9M | $-12.1M | ||
| Q2 25 | $39.8M | $-11.1M | ||
| Q1 25 | $45.6M | $-26.2M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $46.1M | $-13.4M | ||
| Q2 24 | $11.6M | $-16.8M |
毛利率HRMYRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | 71.9% | 53.3% | ||
| Q3 25 | 75.1% | 50.1% | ||
| Q2 25 | 81.0% | 49.6% | ||
| Q1 25 | 82.7% | 45.4% | ||
| Q4 24 | 73.0% | 55.7% | ||
| Q3 24 | 77.0% | 52.1% | ||
| Q2 24 | 81.4% | 50.8% |
营业利润率HRMYRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | 15.8% | 4.1% | ||
| Q3 25 | 27.3% | 1.3% | ||
| Q2 25 | 24.0% | 1.9% | ||
| Q1 25 | 30.4% | -10.8% | ||
| Q4 24 | 27.7% | 13.2% | ||
| Q3 24 | 33.2% | -0.4% | ||
| Q2 24 | 12.4% | -1.0% |
净利率HRMYRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | 9.2% | — | ||
| Q3 25 | 21.2% | -5.6% | ||
| Q2 25 | 19.8% | -5.0% | ||
| Q1 25 | 24.7% | -14.5% | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 24.8% | -6.4% | ||
| Q2 24 | 6.7% | -8.7% |
每股收益（稀释后）HRMYRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.38 | $0.50 | ||
| Q3 25 | $0.87 | $-0.07 | ||
| Q2 25 | $0.68 | $-0.06 | ||
| Q1 25 | $0.78 | $-0.15 | ||
| Q4 24 | $0.85 | $0.05 | ||
| Q3 24 | $0.79 | $-0.08 | ||
| Q2 24 | $0.20 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $67.6M |
| 总债务越低越好 | $163.7M | — |
| 股东权益账面价值 | $870.2M | $419.1M |
| 总资产 | $1.3B | — |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资HRMYRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $775.3M | $96.4M | ||
| Q3 25 | $672.6M | $74.8M | ||
| Q2 25 | $565.3M | $60.5M | ||
| Q1 25 | $507.0M | $71.2M | ||
| Q4 24 | $467.2M | $87.8M | ||
| Q3 24 | $410.5M | $37.2M | ||
| Q2 24 | $346.9M | $64.6M |
总债务HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | $163.7M | $342.1M | ||
| Q3 25 | $168.5M | $344.3M | ||
| Q2 25 | $172.1M | $346.5M | ||
| Q1 25 | $175.7M | $347.4M | ||
| Q4 24 | $179.3M | $348.3M | ||
| Q3 24 | $182.8M | $349.1M | ||
| Q2 24 | $186.4M | $350.0M |
股东权益HRMYRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $870.2M | $449.0M | ||
| Q3 25 | $835.1M | $360.1M | ||
| Q2 25 | $773.1M | $370.4M | ||
| Q1 25 | $720.5M | $381.8M | ||
| Q4 24 | $659.2M | $404.6M | ||
| Q3 24 | $596.8M | $395.5M | ||
| Q2 24 | $538.6M | $405.0M |
总资产HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $999.2M | $1.2B | ||
| Q3 24 | $928.1M | $1.1B | ||
| Q2 24 | $858.4M | $1.1B |
负债/权益比HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.19× | 0.76× | ||
| Q3 25 | 0.20× | 0.96× | ||
| Q2 25 | 0.22× | 0.94× | ||
| Q1 25 | 0.24× | 0.91× | ||
| Q4 24 | 0.27× | 0.86× | ||
| Q3 24 | 0.31× | 0.88× | ||
| Q2 24 | 0.35× | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | — |
| 自由现金流经营现金流 - 资本支出 | $126.0M | — |
| 自由现金流率自由现金流/营收 | 51.7% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 5.61× | — |
| 过去12个月自由现金流最近4个季度 | $347.9M | — |
8季度趋势，按日历期对齐
经营现金流HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | $126.2M | $29.2M | ||
| Q3 25 | $108.7M | $26.5M | ||
| Q2 25 | $79.3M | $-795.0K | ||
| Q1 25 | $34.0M | $-3.5M | ||
| Q4 24 | $75.6M | $61.8M | ||
| Q3 24 | $70.5M | $-14.8M | ||
| Q2 24 | $42.6M | $-9.8M |
自由现金流HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | $126.0M | $27.3M | ||
| Q3 25 | $108.7M | $21.0M | ||
| Q2 25 | $79.3M | $-6.5M | ||
| Q1 25 | $33.9M | $-15.7M | ||
| Q4 24 | $75.0M | $53.8M | ||
| Q3 24 | $70.5M | $-23.7M | ||
| Q2 24 | $42.0M | $-12.9M |
自由现金流率HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | 51.7% | 12.0% | ||
| Q3 25 | 45.4% | 9.7% | ||
| Q2 25 | 39.6% | -2.9% | ||
| Q1 25 | 18.3% | -8.7% | ||
| Q4 24 | 37.3% | 21.4% | ||
| Q3 24 | 37.9% | -11.3% | ||
| Q2 24 | 24.3% | -6.7% |
资本支出强度HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 0.1% | 6.7% | ||
| Q4 24 | 0.3% | 3.2% | ||
| Q3 24 | 0.0% | 4.2% | ||
| Q2 24 | 0.4% | 1.6% |
现金转化率HRMYRBBN
| Q1 26 | — | — | ||
| Q4 25 | 5.61× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 1.53× | — | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 3.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRMY
暂无分部数据
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
